UK Companies House feature
INTERNATIONAL SOCIETY OF SUBSTANCE USE PREVENTION AND TREATMENT PROFESSIONALS
Cash
£59K
-85.9% vs 2023
Net assets
£63K
-20.2% vs 2023
Employees
9
+12.5% vs 2023
Profit before tax
-£16K
-222.4% vs 2023
Profile
- Company number
- 09980630
- Status
- Active
- Incorporation
- 2016-02-01
- Last accounts made up
- 2024-09-30
- Account category
- FULL
- Primary SIC
- 86900
- Hubs
- UK Healthcare
Profit before tax
3-year trend · vs UK Healthcare median
Accounts
3-year trend · latest 2024-09-30
| Metric | Trend | 2022-09-30 | 2023-09-30 | 2024-09-30 |
|---|---|---|---|---|
| Turnover | — | — | — | |
| Operating profit | — | — | — | |
| Profit before tax | £16,943 | £12,984 | -£15,895 | |
| Net profit | £14,289 | £11,386 | -£15,895 | |
| Cash | £519,447 | £418,198 | £59,144 | |
| Total assets less current liabilities | £67,463 | £78,849 | £62,954 | |
| Net assets | — | — | — | |
| Equity | — | £78,849 | £62,954 | |
| Average employees | 8 | 8 | 9 | |
| Wages | — | — | — |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102 §1A
- Reporting scope
- Standalone (parent only)
- Abridged
- Yes — abridged accounts (limited disclosure)
- Auditor
- HW Fisher Audit
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. The directors are confident that the company can continue as a going concern for a period of at least twelve months from the date of approval of these financial statements. The directors also have a reasonable expectation that the company has adequate resources to continue in operation and that future cash inflows are assured. This is due to an active grant agreement with the U.S. Department of State's Bureau of International Narcotics and Law Enforcement Affairs (INL), ISSUP's main funder. A strong relationship has been established due to six previous years of funding, and a new grant agreement has been approved to 30 September 2026. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.”
Subsidiaries
- Friends of ISSUP · 100% held · State of Montana, USA · working to deliver against the same objectives as ISSUP, with particular focus in North America.
Significant events
- “ISSUP has been working hard to modify its internal structure to strengthen scientific and technical guidance, expertise, and oversight. In line with this, the ISSUP team underwent some exciting changes in 2024. The year was marked by several key developments that reflect ISSUP's commitment to professionalism, scientific rigor, and global impact.”
- “ISSUP bolstered its scientific capabilities by welcoming Dr. Goodman Sibeko as Scientific Advisor and Hala Najm as Scientific Support Coordinator. These additions ensure that ISSUP's information remains evidence-based anc scientifically rigorous. ISSUP also updated its Code of Ethics, reinforcing its core values of professionalism and ethical conduct.”
- “Sadly, ISSUP had to say goodbye to Jeff Lee, a founding figure in the creation of ISSUP who played a major role in drug prevention and projects spanning more than 80 countries arourd the world. Jeff retired in March 2024 from his role as a Senior Consultant following a 9-year career with ISSUP.”
- “ISSUP expanded its international partnerships, notably teaming up with the Global Women's Network to address substance use disorders among women. ISSUP actively participated in key global events, including the 67th Commission on Narcotic Drugs ir Vienna, co-hosting an event on synthetic drug threats at the UK's House of Lords, attending UNODC's "Friends in Focus" peer-to-peer drug prevention programme consultation, and the European Society for Prevention Research Conference in Italy.”
- “The "Art of Healing" event in Thessaloniki, hosted by ISSUP Greece, was a major highlight in this year's calendar, attracting 800 participants from 123 countries. ISSUP also made significant progress in delivering training initiatives. These include conducting Paraguay's first national Children and Adolescents for a Drug-Free Life (CHILD) training course, holding Universal Treatment Curriculum training for Faith-Based Organisations in Panama, launching the Spanish edition of the INEP Plus Facilitators Course, and offering the European Prevention Curriculum (EUPC) Basic Module in Thessaloniki.”
- “The period 2023-2024 saw ISSUP grow to over 38,000 members worldwide, our highest level ever. On the back of this, many members have participated in webinars, events and trainings, which has helped raise the Society's profile and has directly led to new members joining.”
- “ISSUP continued to grow its global network by establishing new National Chapters in El Salvador, Türkiye, Tanzania, and Panama. Our National Chapters continue to play a crucial role in localising ISSUP's mission and expanding its reach. We want to extend a heartfelt thank you to our National Chapters for their incredible work. Your dedication and enthusiasm in advancing the mission of ISSUP are truly admirable and deserving of commendation.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
6 active · 11 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| TRAVIS-ROBERTS, Joanna Kathryn | Secretary | 2016-02-01 | — | — |
| AGWOGIE, Martin Osayande | Director | 2020-10-13 | Dec 1970 | Nigerian |
| EVANS, Vivienne Marion | Director | 2016-02-17 | Oct 1947 | British |
| GORLERO, Carolina Ines | Director | 2025-02-10 | Dec 1981 | Argentine |
| HEAPS, Melody Mary | Director | 2016-02-01 | Jul 1943 | American |
| MIOVSKY, Michal, Professor | Director | 2020-02-13 | Sep 1975 | Czech |
Show 11 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ABELLA JR, Clemente | Director | 2016-02-10 | 2018-12-01 |
| FOXCROFT, David, Prof | Director | 2016-02-24 | 2019-03-12 |
| GAKUNJU, Richard Mwangi, Dr | Director | 2016-02-10 | 2018-12-01 |
| LE ROUX, Louina | Director | 2016-02-12 | 2018-12-03 |
| LEE, Jeffrey Talbot | Director | 2016-02-01 | 2017-10-31 |
| MARTELLI, Paulo Vicente | Director | 2016-02-10 | 2018-12-05 |
| RIBALDO, Carlos Alberto Torres | Director | 2016-02-10 | 2019-01-14 |
| SETIAWAN, Antonius Riva | Director | 2016-12-01 | 2018-06-15 |
| SLOBODA, Zili, Dr | Director | 2016-02-10 | 2018-12-05 |
| THAU, Susan Rosenberg | Director | 2016-02-10 | 2025-12-04 |
| TRAVIS-ROBERTS, Joanna Kathryn | Director | 2016-02-01 | 2019-09-03 |
Ownership
Persons with significant control
Filing timeline
Last 20 of 57 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-01-15 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-12-16 | CH01 | officers | change person director company with change date |
| 2025-12-08 | TM01 | officers | termination director company with name termination date |
| 2025-09-29 | AA | accounts | accounts with accounts type full |
| 2025-02-13 | AP01 | officers | appoint person director company with name date |
| 2025-01-29 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-09-25 | AA | accounts | accounts with accounts type full |
| 2024-01-16 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-06-23 | AA | accounts | accounts with accounts type small |
| 2023-01-16 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-09-13 | AA | accounts | accounts with accounts type small |
| 2022-01-27 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2021-09-25 | AA | accounts | accounts with accounts type small |
| 2021-01-26 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2020-11-03 | AA01 | accounts | change account reference date company previous shortened |
| 2020-10-29 | AA | accounts | accounts with accounts type small |
| 2020-10-16 | AP01 | officers | appoint person director company with name date |
| 2020-10-06 | AP01 | officers | appoint person director company with name date |
| 2020-01-23 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2019-10-10 | AA | accounts | accounts with accounts type small |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Composite activity score · components 0–100 · reference 2026-05-10
27.2
COLD
/ 100
- Filings velocity 33
- Capital events 0
- Officer churn 25
- Headcount trajectory 63
- Accounts trajectory 30
- 4 filing(s) in last 12 months
- 0 appointed, 1 resigned (12mo)
- Employees +12% YoY
- Total Assets Less Current Liabilities -20% YoY